Diabetes Drugs Go Head-to-Head in Study (HealthDay)

HealthDay - THURSDAY, Dec. 3 (HealthDay News) -- A class of drugs still taken by millions of people with type 2 diabetes is associated with a higher risk of dying and heart failure than the newer treatment metformin, researchers say.